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Original Article
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Abstract
Accurate and physiologically meaningful biomarkers for human aging are key to assessing antiaging therapies. Given ethnic differences in 
health, diet, lifestyle, behavior, environmental exposures, and even average rate of biological aging, it stands to reason that aging clocks trained 
on datasets obtained from specific ethnic populations are more likely to account for these potential confounding factors, resulting in an 
enhanced capacity to predict chronological age and quantify biological age. Here, we present a deep learning-based hematological aging clock 
modeled using the large combined dataset of Canadian, South Korean, and Eastern European population blood samples that show increased 
predictive accuracy in individual populations compared to population specific hematologic aging clocks. The performance of models was also 
evaluated on publicly available samples of the American population from the National Health and Nutrition Examination Survey (NHANES). 
In addition, we explored the association between age predicted by both population specific and combined hematological clocks and all-cause 
mortality. Overall, this study suggests (a) the population specificity of aging patterns and (b) hematologic clocks predicts all-cause mortality. 
The proposed models were added to the freely-available Aging.AI system expanding the range of tools for analysis of human aging.
Keywords: Biochemistry aging clocks, Biological age, Deep Learning, Deep Neural Networks, Machine Learning.
According to the World Health Organization, from 2000 to 2015 the 
global life expectancy experienced its fastest growth since the 1990s, 
increasing by 5 years within this period (1). Life expectancy, however, 
varies across countries (1) and even across different regions within one 
country (2). The underlying factors driving this variability often unclear 
and research into subpopulation specific life expectancies could facilitate 
the identification of more comprehensive country and region  specific 
aging patterns. Toward this end, we are investigating the populations 
of three diversely aging including Canada, South Korea, and Eastern 
Europe. Aging-dependent health care and social costs are rapidly 
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increasing in each of these three (3). Increased life expectancy, even when 
coupled with decreasing birth rate, is outpacing economic growth (4). 
Assessing aging is the first step towards interventions to reduce the ill-
ness, social, and economic-burden associated with aging (5).
Growing pre-clinical experimental evidence suggests the feasi-
bility of finding interventions for extending human health span 
(6). Evaluating such interventions might require long follow-up 
periods and entails the possibility of failing to translate preclin-
ical success into improved clinical outcomes (7). The search for ef-
fective geroprotectors (i.e., anti-aging molecules) shown few positive 
results in humans (8,9). Biomarkers of aging, or aging clocks, are 
promising tools with the potential to provide a quantitative foun-
dation upon which to evaluate the therapeutic efficacy of clinical 
healthspan-extending interventions (10). Much progress has been 
made in measuring aging biomarkers using easily obtained data 
such as blood DNA methylation (11,12), transcriptomics (13), and 
metabolomics (14). Data of different modalities provide different 
levels of precision regarding the magnitude and rate of age-related 
changes, and biomarkers vary according to their resolving ability. 
While methylation-based aging clocks provide the most accurate 
representation of chronological age to date, epigenetic information 
is relatively stable (15). As such, epigenetic aging clocks appear to be 
comparatively less effective in quantifying the effect of behavioral, 
lifestyle, environmental, and interventional factors upon the rate of 
biological aging (16). Furthermore, epigenetic clocks are not as prac-
tically measurable as markers quantifying transcriptional (13,17) 
and the standardized accredited assays biochemical (14) markers. 
Nonetheless, the most accurate methods of calculating biological age 
is a subject of ongoing debate, and recent studies suggest that a suite 
of biomarkers, rather than any individual biomarker, constitute the 
most effective means of assessing the health status of a patient (18).
Here, we present several deep learning-based predictors of bio-
logical age trained upon population-specific blood biochemistry and 
hematological cell count datasets. Previously, we showed that blood 
biochemistry could be used to assess the biological age of a patient 
(14), an approach that has several advantages compared to other 
aging clocks, including strong correlation with chronological age 
(coefficient of determination is greater than 0.8), constancy across 
the entire adult age range, lack of influence of sex, and ease of assess-
ment compared to methylation-based aging clocks. However, such 
aging clocks seem to be population-specific (19), therefore, robust 
aging clocks should be trained upon population-specific data. While 
current research appears to validate the importance of ethnicity 
upon life expectancy and mortality rates (20–22), the effect of ethni-
city on blood biochemistry-based biomarkers of aging remains un-
clear. In the present study we decided to focus on emerging machine 
learning (ML) techniques, such as deep neural networks (DNNs), in 
the construction of our aging clocks. DNNs are perceived as game-
changing methods in data analysis due to their capacity to capture 
hidden underlying features and learn complex representations of 
highly multidimensional data (23).
Materials and Methods
To perform this study, we trained a series of DNNs on anonymized 
blood tests for patients from three distinct ethnic populations: 
Korean, Canadian, and Eastern European. We compared the predic-
tive accuracy of our deep learning models first when trained using 
population specific data, and then when using a combined and eth-
nically diverse dataset that includes patients from all three patient 
populations (see Figure 1). We used the same feature space of 20 
blood biochemistry markers, cell counts, and sex to train three sepa-
rate deep networks on three specific ethnic populations. Here, we 
excluded samples from patients younger than 20 years of age given 
the high error rate in this age group and the different biochemistry 
reference ranges associated with adolescents and children.
Data Overview
Anonymized blood test records were kindly provided by Alberta Health 
(with IRB approval), Gachon University Gil Medical Center, and an 
independent laboratory, Invitro. Patient data were fully anonymized. In 
total, four datasets containing 20,699 samples for the Canadian popu-
lation, 65,760 samples for the South Korean population, and 55,920 
samples for the Eastern European population. Population dataset char-
acteristics are described in Supplementary Table 1.
To investigate the predictive power of trained models on the 
publicly available data and to assess the predictive value of hemato-
logic clocks to predict all-cause mortality, we analyzed the National 
Health and Nutrition Examination Survey (NHANES) dataset. We 
obtained retrospective laboratory data and demographics data for 
1996–2016 years of and mortality data for 1996–2011 years using 
the National Center for Health Statistics website (https://www.cdc.
gov/nchs/index.htm). The collected NHANES dataset contained 
55,751 samples with blood test values, which were used to predict 
the age of patients. The blood test dataset was merged with mor-
tality dataset by anonymized patient unique ids resulting in a table 
of 2,768 samples.
For mortality analysis, we explored Canadian population dataset 
(with known 340 deaths) and NHANES dataset (with known 873 
deaths).
Figure 1. Study design. First, blood samples of three populations (Canadian, 
Korean and Eastern European) with 21 the most relevant features with 
maximum samples available were used to train three population  specific 
predictors. Afterwards, the resulting dataset consisting of samples from all 
three populations was used to train and test DNNs for predicting patient age.
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Training and Testing Set Design
Models were trained on 19 blood test features (in this paper, we 
refer to features implying input data or variables), 15 of which are 
biochemistry markers, including Albumin, Glucose, Hemoglobin, 
Cholesterol, Sodium, Urea, LDL Cholesterol, Triglycerides, 
Hematocrit, HDL Cholesterol, Total Protein, Calcium, Creatinine, 
Potassium, and Total Bilirubin, and four are cell count markers, 
including Erythrocytes,  and Platelet count. While these markers 
are common parameters measured for South Korean and Eastern 
European blood tests, several of these markers were not present in 
the full Canadian dataset. Therefore, in order to obtain the same fea-
ture space for all three population specific datasets, values of Urea, 
Total Protein, Calcium, and total bilirubin for part of the Canadian 
dataset were reconstructed via regression analysis using samples 
with all 19 parameters (Supplementary Table  2). Values of blood 
tests were treated as continuous values while sex and population 
labels were treated as binary and dummy variables, respectively. We 
split the data into the training and testing sets at an 80/20 ratio. 
DNNs Implementations
We treated age prediction as a regression task, that is, the model 
takes a vector of blood test values and returns a single value of pa-
tient age. Here we decided to use a deep model with multiple layers, 
which allows fitting data with high-level of dependencies between 
input features (blood biochemistry and cell counts) and the output 
feature (age).
We used multilayer feed-forward neural networks as deep mod-
els (ie, having more than three layers) and the Python implemen-
tation of the Keras (https://keras.io/) library with Theano (http://
deeplearning.net/software/theano/) backend to build and train the 
neural networks. Grid search over a space of model parameters was 
used for optimization in order to find the best performing network 
architecture. We minimized the mean absolute error (MAE) loss 
function using a back propagation algorithm. We used the Leaky 
ReLU activation (24) function after each layer, EVE (25) as an opti-
mizer of the cost function, and a dropout (26) with 35% probability 
after each layer for the purposes of regularization. We trained the 
networks with fivefold cross validation to compensate for overfitting 
and to receive more robust performance metrics. All experiments 
were conducted using an NVIDIA Titan X (Maxwell) graphics 
processing unit.
We also compared DNNs with a set of conventional ML algo-
rithms, including Elastic Net, Random Forest, Partial Least squares, 
Gradient Boosting Machines, and Principal component Analysis. All 
models were implemented using the Scikit-learn library.
Feature Importance Analysis
To address the interpretability problem of DNNs and yield more 
insight into the data, we have applied permutation feature import-
ance (PFI) analysis to rank input blood markers according to their 
importance in terms of age prediction. We applied PFI for the best 
performing models on each dataset. PFI is a wrapper method, which 
assigns the relative importance to input features based on the level of 
decreased age prediction accuracy after each feature random reshuf-
fling. The larger the decrease in the accuracy of age prediction, the 
more important the input feature is. We applied the same technique 
for the age prediction in the present study (14), with some modifica-
tion. Sex and population binary vectors were wrapped randomly, but 
systematically replaced with the opposite values.
Statistical Analysis
The following metrics were used to evaluate the accuracy of the age 
prediction models:
1) Pearson correlation coefficient
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where yi
 is age prediction of the model, yi is a chronological 
age value, N is a number of samples. Aging ratio is the ratio of 
predicted age over observed chronological age. Log2Aging ratio 
of 1 means that the sample is predicted two-fold older than a 
chronological age and Log2Aging ratio of −1 means sample is 
predicted half as old
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;where A y yi i= − +[ ]ε ε;  and yi  
is an age prediction of the model, yi  is a true age value. For 
instance, if epsilon ( )ε is 5 and the DNN model predicts age of 
55 but the real age is 50 or 60, then by epsilon accuracy such 
sample would be considered as correctly classified.
To evaluate the association of the predicted age acceleration or age 
slowdown with all-cause mortality, we calculated the hazard ratios. 
We analyzed survival time data (from the age at blood draw until age 
at death or last follow-up). For hazard analysis by group, we used 
“coxph” function from the “survival” R package (27).We adjusted 
Cox models to chronological age and sex. A delta ( )∆  group was 
assigned according to the difference between predicted and actual age 
of the sample. Cases where ∆ ≥ 5,  the samples are predicted older 
than their chronological age, were compared to norms ( ),− ≤ ≤5 5∆  
similarly, cases where ∆ ≤ −5 , samples predicted young, were com-
pared to norms ( ).− ≤ ≤5 5∆
Results
Population Specific Biomarkers of Human Aging
To develop both universal and population specific aging clocks, we 
trained a series of DNNs on anonymized blood tests for patients 
from three distinct ethnically diverse populations: South Korean, 
Canadian, and Eastern-European. The best performing predictor 
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trained upon the Canadian population specific dataset demonstrated 
an MAE of 6.36  years and an R2 of 0.52 (Figure  2A and D and 
Table  1). Meanwhile, the best-performing predictor trained upon 
the South Korean population specific dataset demonstrated an MAE 
of 5.59 and an R2 of 0.49 (Figure 2B and E and Table 1). Lastly, 
the best-performing predictor trained upon the Eastern European 
population specific dataset demonstrated an MAE of 6.25, an R2 of 
0.69 (Figure 3C and F and Table 1). The best performing predictor 
of our previously reported blood biochemistry-based aging clock, 
Aging.AI, demonstrated R2  =  0.80 and MAE  =  6.07  years, while 
the entire ensemble demonstrated 83.5% epsilon-accuracy R2 = 0.82 
and MAE = 5.55 years. Aging.AI was trained on over 56,000 sam-
ples of 41 blood biochemistry and cell counts markers of patients 
from Eastern Europe.
To further investigate the importance of population in age pre-
diction, we tested Canadian, South Korean, and Eastern European 
population of samples on the networks trained on each single popu-
lation, the results of which are summarized in Table  1. Eastern 
European samples demonstrated the greatest increase in MAE 
(9.25  years compared to 6.25  years) and R2 (0.27 compared to 
0.69) when tested on the networks trained on the Canadian popu-
lation. Indeed, almost the same increase in MAE (8.52 compared to 
6.25  years) and R2 (0.34 compared to 0.69) were observed when 
the Eastern European samples were tested on the networks trained 
on the South Korean population. A similar situation is observed for 
Canadian and Korean populations tested on the Eastern European 
network (MAE of 9.68  years compared to 6.36  years and R2 of 
0.24 compared to 0.52 for the Canadian population, and MAE of 
9.77 years compared to 5.59 years and R2 of 0.29 compared to 0.49 
for Korean population). In contrast, the network trained on South 
Koreans appear to perform almost as well as it does on Canadians, 
and vica versa.
Next, we trained the age predictor on the combined datasets with 
population type included as a feature. The best-performing network 
achieved an R2 of 0.65 and MAE of 5.94 years for the combined 
population dataset (Figure 3A and B; Table 1), an R2 of 0.52 and 
MAE of 6.17 years when tested on the Canadian population, an R2 
of 0.49 and MAE of 5.60 years when tested on the South Korean 
population and, an R2 of 0.70 and MAE of 6.22 years when tested 
on the Eastern European population (Figure 4; Table 1). Using the 
datasets of all three populations to train the network resulted in an 
increase in the accuracy of age prediction for both the combined 
population as well as for each population individually (Table 1 and 
Supplementary Figure 2).
To determine which markers contributed to the predictive ac-
curacy of the network the most and to evaluate possible differ-
ences in biological aging between each distinct population, we 
performed PFI analysis as described in Putin et  al. (13). Given 
that the age distribution and sample size of each population spe-
cific dataset differed (Supplementary Figure 1), we equalized the 
sample size and age distribution of each set, so that an equal 
number of samples from each age-group of each population spe-
cific dataset were included in the final dataset, in order to avoid 
incorrect ranking of population type during PFI. Additionally, we 
trained a separate model on a combined dataset excluding popu-
lation type as a feature to evaluate the change in the predictive 
accuracy of the model.
Glucose, albumin, sex, urea, hemoglobin, HDL cholesterol, and 
triglycerides were ranked as the seven most important markers for 
the Canadian population. Hemoglobin, albumin, erythrocytes, sex, 
cholesterol, glucose, and sodium were ranked as the seven most im-
portant markers for the South Korean population. Albumin, glucose, 
LDL cholesterol, gender, urea, and erythrocytes were ranked as the 
seven most important markers for the Eastern European popula-
tion. The biochemistry markers found to be most important for the 
predictive accuracy of all three population specific predictors were 
Albumin, hemoglobin, urea, and glucose (Figure  5A–D). For the 
model trained on samples from all three populations, we found that 
the population-type ranked as one of the most important features for 
age prediction (Figure 5E). Consistent with this finding, the network 
trained on a feature space that included population type as a feature 
demonstrated higher performance than the network that excluded 
population type as a feature (R2 of 0.65 compared to 0.62 and MAE 
of 5.94 compared to 6.09  years) (Table  1). Exclusion of sex as a 
feature also significantly reduced the accuracy of the model trained 
on all three populations (R2 of 0.61 compared to 0.65 and MAE 
of 6.23 years compared to 5.94 years), but not for models trained 
on the individual populations (Table 1). In addition, the age of fe-
male samples tends to be predicted more accurately compared to 
male samples for South Korean and Eastern European populations 
by both population specific models and the universal model, how-
ever, no significant difference is observed. Notably, female samples 
in the Canadian population were predicted less accurately compared 
to male samples.
Figure 2. Actual chronological age vs predicted age for Canadian (A), Korean 
(B), and European (C) populations of patients. The linear regression line is 
shown in dark grey. Log2transformed Aging ratio for for Canadian (D), Korean 
(E), and European (F) population predictions. Log2Aging ratio of 1 means that 
sample is predicted twice older than a chronological age and Log2Aging ratio 
of −1 means sample is predicted half as old.
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Validation of Models
The National Health and Nutrition Examination Survey (NHANES) 
dataset were used to validate our models. We excluded population 
as a feature in models trained on the individual Canadian, South 
Korean and Eastern European datasets, as well as the combined 
dataset to predict the age of NHANES samples based on their blood 
biochemistry values.
Networks trained on Eastern European and all samples demon-
strated higher accuracy in prediction of age of NHANES samples 
and achieved R2 of 0.46 and MAE of 7.88 and R2 of 0.50 years and 
MAE of 9.93 years, respectively (Table 1; Figure 6). This perform-
ance coincides with the performance of population specific networks 
tested on other populations. Interestingly, for the NHANES dataset 
the difference in accuracy of age prediction for male and female sam-
ples is higher compared to internal datasets investigated in this study 
and the age of female samples is predicted less accurately compared 
to male samples.
To investigate the predictive ability of deep hematologic aging 
clocks on mortality, we employed chronological age- and sex-
adjusted Cox regression models. Samples predicted younger con-
sistently demonstrated a decrease in  the hazard ratio (from 49.2 
to 31.5% for the Canadian dataset and from 30.4 to 24% for the 
NHANES dataset), while samples predicted older demonstrated a 
Figure  4. Actual chronological age vs predicted age for (A) Canadian, (B) 
Korean, and (C) European patient populations tested on the network trained 
on all population samples. Linear regression lines are shown in dark grey. 
Log2, transformed aging ratio for (D) Canadian, (E) Korean, and (F) European 
populations tested on the network trained on all population samples. 
Log2Aging ratio of 1 means that sample is predicted twice older than a 
chronological age and Log2Aging ratio of −1 means sample is predicted half 
as old.
Figure  5. Feature importance plots of the model trained on (A) Canadian 
population samples, (B) on Korean population samples, and (C) on Eastern 
European population samples. Permutation feature importance (PFI) method 
was used to rank blood markers and sex by their importance in age prediction. 
(D) The top seven most important features across all predictors trained on 
different populations. Albumin, sex, hemoglobin, and urea are ranked as 
the most important markers for age prediction in all three models; (E) the 
most important markers for the network trained on the three populations. 
Albumin, glucose, and erythrocyte count were ranked as the most markers 
for age prediction in this model. PFI method was applied to rank blood 
markers, sex and population by their importance in age prediction.
Figure  3. (A) Actual chronological age vs predicted age for the resulting 
network trained and tested on the all three populations. The linear regression 
line is shown in dark grey. (B) Log2 transformed aging ratio. Log2Aging ratio 
of 1 means that sample is predicted twice older than a chronological age and 
Log2Aging ratio of −1 means sample is predicted half as old.
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significant increase in the hazard ratio (from 69.5 to 185.8% for the 
Canadian dataset and from 32.6 to 66.2% for the NHANES data-
set) (Figure 6E, Supplementary Table 3).
Discussion
Here, we present several novel hematological aging clocks trained 
using data from several diverse populations. The best-performing 
predictor achieved an MAE of 5.94  years having greater predict-
ive accuracy than the best-performing predictor of our previously 
reported aging clock (which achieved an MAE of 6.07 years), despite 
being trained on a narrower feature space (21 compared to 41 fea-
tures). Importantly, our deep learned predictors outperformed con-
ventional ML models (Supplementary Figure 3). These results are in 
line with the hypothesis that ethnically-diverse aging clocks have the 
potential to predict chronological age and quantify biological age 
with greater accuracy than generic aging clocks. Furthermore, they 
have a greater capacity to account for the confounding effect of eth-
nic, geographic, behavioral, and environmental factors upon the pre-
diction of chronological age and the measurement of biological age.
Albumin, glucose, urea and hemoglobin were among the most 
important blood biochemistry parameters for all three popula-
tion  specific predictors. Albumin is the most prevalent protein 
in blood and its primary function is the regulation of oncotic 
pressure, which is critical for transcapillary fluid dynamics, and 
deviations in serum albumin levels is associated with a number 
of pathophysiological conditions (28). Hypoalbuminemia (i.e. 
abnormally low levels of albumin) is often associated with mal-
nutrition, liver disease, injury, chronic inflammation (29) and the 
aging process (30). Blood glucose levels, on the contrary, tend to 
increase with age, and glucose is able to modify proteins via irre-
versible glycosylation, a feature that is directly associated with 
the aging process (31). In this regard, low-calorie and low-glucose 
diets are considered to be one of the most effective antiaging inter-
ventions, as well as metformin, a biguanide that reduces glucose 
levels. Levels of serum urea also increase with age, which is asso-
ciated with age-related decrease in muscle mass (32). Age-related 
decrease in hemoglobin is common in the elderly (33), a condition 
that increases the risk of cardiovascular disease, cognitive decline 
and an overall decline in quality of life (34). Our hematological 
clock is consistent with what is already known about the biology 
and pathophysiology of aging. While the blood parameters are 
not accurate biomarkers of aging by themselves, when analyzed 
in combination they can be used to reasonably accurately predict 
chronological and biological age.
Other groups have reported previously upon sex and ethni-
city specific differences in the rate of biological aging as for example 
quantified by epigenetic aging clocks (35). Here, we report similar 
findings obtained through the use of hematologic aging clocks. The 
results of our PFI analysis also found that sex was ranked as one 
of the important features for age prediction by our system, which 
is consistent with sex-specific differences in the rate of aging as 
reported by many other groups; indeed, the phenomenon of sex-
dependent differences in aging rates has been widely investigated in 
model organisms and humans with fairly consistent results (35,36). 
However, the model trained on both males and females predicts age 
equally well for both sexes, despite the fact that blood biochemistry 
values vary between males and females and that such parameters as 
creatinine, hemoglobin, or HDL Cholesterol have sex-specific nor-
mal reference ranges.
The performance of population specific networks is better on the 
population dataset they were trained on. At the same time, the inclu-
sion of a population into the training set increases the accuracy of 
age prediction for this population. Accordingly, the network trained 
on all populations demonstrates almost the same level of perform-
ance compared to population  specific networks tested on popula-
tion  specific data. Population type was also ranked as one of the 
most important markers for age quantification perhaps indicating 
that different populations show variability in their aging phenotype. 
Indeed, our PFI analysis determined the population type to be one of 
the most important features in our model, and our population spe-
cific predictors achieved greater predictive accuracy than our previ-
ously reported DL-based age predictor, despite being trained on a 
narrower feature space. However, we should emphasize that, while 
the tests used are completely standardized it is possible that slight 
biases between batches and labs in different regions could introduce 
subtle changes in the results. This could perhaps contribute to some 
of the differences observed between populations.
Figure  6. Validation of models. Actual chronological age vs predicted age 
for NHANES dataset using networks trained on Canadian (A), Korean (B), 
European (C), and (D) all patient population samples. The linear regression 
lines are shown in dark grey. Networks trained on both E.  European and 
all patient samples demonstrated the higher accuracy of age prediction of 
NHANES dataset. (E) Hazard ratios for the NHANES and Canada datasets. 
A  Cox proportional hazards regression model was used to relate survival 
time to the accelerated aging group (delta >5) and slowed aging group (delta 
<5). Patients predicted younger their chronological age has a lower mortality 
risk, while patients predicted older has a higher risk. Each row represents a 
hazard ratio and 95% confidence interval. Note: “∗∗∗” for p-value of .001; “∗∗” 
for p-value of .01; “∗” for p-value of .05.
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Previously, Cohen et  al. showed age prediction for four blood 
test datasets obtained from multiple different patient populations 
of non-Eastern European descent, using a freely available validated 
blood-based aging clock (www.Aging.AI) (14). Authors highlighted 
that the lower accuracy reported in their study was partly the result 
of using a much lower number of input samples [ie, 100 samples 
compared to 6,242 in our previous study (14)], the limited age range 
of the samples, and a minimum allowed number of input markers 
(ie, 10 markers compared to 41 in our previous study (14)). Our 
current results for the NHANES dataset correspond with the results 
presented by Cohen and colleagues, DNNs trained upon one popu-
lation show lower accuracy when predicting age on a different popu-
lation. However, a network trained on a diverse population, such as 
Eastern Europeans or on multiple combined datasets demonstrated 
higher accuracy. Notably, by using the NHANES and Canadian 
datasets we could test a key requirement for aging clocks: the ability 
to predict mortality. Importantly, patients that were found to have 
an older blood-age than their chronological age had increased risk 
of dying and vice versa. A younger blood age could, therefore, be a 
useful outcome measure in interventions for healthy aging.
DL-based hematological aging clocks, even when trained on a 
limited feature space, demonstrate reasonably high accuracy in pre-
dicting chronological age. The application of DNNs to the predic-
tion of chronological age and the quantification of biological age 
allows us to characterize nonlinear dependencies between blood 
parameters and age. Further, the population-adjusted aging clocks 
display high levels of generalization, resulting in increased perform-
ance when applied to chronological age prediction and biological 
age quantification of both ethnically-homogenous and heterogenous 
patient populations. Indeed, going forward we will include add-
itional population specific blood biochemistry datasets in order to 
further increase the predictive power and general utility of DL-based 
hematologic aging clocks. Importantly, the continuously updated 
Aging.AI system is freely available on the www.aging.ai website.
Supplementary Material
Supplementary data is available at The Journals of Gerontology, 
Series A: Biological Sciences and Medical Sciences online.
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